Stempeutics out licenses its stem cell product to Cipla for treating Diabetic Foot Ulcer
Under this agreement, Cipla will get the exclusive marketing rights for five years in India for DFU product with Stempeutics…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Stempeutics Research
Stempeutics to launch stem cell device in India by mid 2016
The device will be used for later treatment of osteoarthritis and diabetic foot ulcer to even breast augmentation surgery…
Stempeutics receives ODD in the European Union for Stempeucel
Stempeucel is used in the treatment of Thromboangiitis Obliterans
Stempeutics receives ATMP classification from EMA for its novel stem cell drug Stempeucel
The first stem cell drug-based on pooling technology to be granted ATMP classification
Stempeutics Research, a group company of…